Anti-TNF-α treatment modulates SASP and SASP-related microRNAs in endothelial cells and in circulating angiogenic cells
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
// Francesco Prattichizzo 1,2 , Angelica Giuliani 1 , Rina Recchioni 3 , Massimiliano Bonafè 4 , Fiorella Marcheselli 3 , Sabrina De Carolis 4 , Anna Campanati 5 , Katia Giuliodori 5 , Maria Rita Rippo 1 , Francesca Brugè 6 , Luca Tiano 6 , Carla Micucci 1 , Antonio Ceriello 2 , Annamaria Offidani 5 , Antonio Domenico Procopio 1,3 and Fabiola Olivieri 1,3 1 Department of Clinical and Molecular Sciences, DISCLIMO, Università Politecnica delle Marche, Ancona, Italy 2 Insititut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) and Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Barcelona, Spain and IRCCS MultiMedica Sesto San Giovanni (MI), Italy 3 Center of Clinical Pathology and Innovative Therapy, National Institute INRCA-IRCCS, Ancona, Italy 4 Department of Experimental, Diagnostic and Specialty Medicine, DIMES, University of Bologna, Bologna, Italy 5 Dermatology Clinic, Department of Clinical and Molecular Medicine, Università Politecnica delle Marche, Ancona, Italy 6 Department of Clinical and Dental Sciences, DISCO, Università Politecnica delle Marche, Ancona, Italy Correspondence to: Anna Campanati, email: // Keywords : miR-146a-5p, miR-126-3p, SASP, HUVEC, replicative senescence, Gerotarget Received : December 04, 2015 Accepted : February 14, 2016 Published : March 02, 2016 Abstract Endothelial cell senescence is characterized by acquisition of senescence-associated secretory phenotype (SASP), able to promote inflammaging and cancer progression. Emerging evidence suggest that preventing SASP development could help to slow the rate of aging and the progression of age-related diseases, including cancer. Aim of this study was to evaluate whether and how adalimumab, a monoclonal antibody directed against tumor necrosis factor-α (TNF-α), a major SASP component, can prevent the SASP. A three-pronged approach has been adopted to assess the if adalimumab is able to: i) modulate a panel of classic and novel senescence- and SASP-associated markers (interleukin [IL]-6, senescence associated-β-galactosidase, p16/Ink4a, plasminogen activator inhibitor 1, endothelial nitric oxide synthase, miR-146a-5p/Irak1 and miR-126-3p/Spred1) in human umbilical vein endothelial cells (HUVECs); ii) reduce the paracrine effects of senescent HUVECs’ secretome on MCF-7 breast cancer cells, through wound healing and mammosphere assay; and iii) exert significant decrease of miR-146a-5p and increase of miR-126-3p in circulating angiogenic cells (CACs) from psoriasis patients receiving adalimumab in monotherapy. TNF-α blockade associated with adalimumab induced significant reduction in released IL-6 and significant increase in eNOS and miR-126-3p expression levels in long-term HUVEC cultures. A significant reduction in miR-146a-5p expression levels both in long-term HUVEC cultures and in CACs isolated from psoriasis patients was also evident. Interestingly, conditioned medium from senescent HUVECs treated with adalimumab was less consistent than medium from untreated cells in inducing migration- and mammosphere- promoting effects on MCF-7 cells. Our findings suggest that adalimumab can induce epigenetic modifications in cells undergoing senescence, thus contributing to the attenuation of SASP tumor-promoting effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflamm‐aging: An Evolutionary Perspective on Immunosenescence
FRANCESCHI, C., BONAFÈ, M., VALENSIN, S., OLIVIERI, F., DE LUCA, M., OTTAVIANI, E., & DE BENEDICTIS, G. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06651.x · Cited by 5,358 · cited 1×
“The senescence status of stromal cells, including endothelial cells (ECs), plays a major role in inflammaging [1], the low-grade, chronic, and systemic inflammatory condition associated to aging [2].”
BackgroundSelf-citationCellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670 · cited 2×
“Notably, removal of senescent cells in animal models, is able to prolong lifespan and healthspan [13].”
BackgroundMethodThe Achilles' heel of senescent cells: from transcriptome to senolytic drugs
Zhu, Y., Tchkonia, T., Pirtskhalava, T., Gower, A. C., Ding, H., Giorgadze, N., Palmer, A. K., Ikeno, Y., Hubbard, G. B., Lenburg, M., et al. (2015) · Aging Cell · doi:10.1111/acel.12344 · Cited by 2,584
Cellular senescence in aging and age-related disease: from mechanisms to therapy
Childs, B. G., Durik, M., Baker, D. J., & van Deursen, J. M. (2015) · Nature Medicine · doi:10.1038/nm.4000 · Cited by 2,363 · cited 1×
“Cellular senescence is related to the acquisition of a discrete phenotype, the so called senescence-associated secretory phenotype (SASP), characterized by the activation of a pro-inflammatory transcriptional program [3-6].”
BackgroundA complex secretory program orchestrated by the inflammasome controls paracrine senescence
Acosta, J. C., Banito, A., Wuestefeld, T., Georgilis, A., Janich, P., Morton, J. P., Athineos, D., Kang, T.-W., Lasitschka, F., Andrulis, M., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2784 · Cited by 2,278 · cited 6×
“However, the present findings are in line with earlier reports [9, 17] that it is possible to dissociate the SASP from senescence, and encourage the search for substances, synthetic or natural, that not only suppress but also restrain the SASP.”
BackgroundResultInfluentialOncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network
Kuilman, T., Michaloglou, C., Vredeveld, L. C. W., Douma, S., van Doorn, R., Desmet, C. J., Aarden, L. A., Mooi, W. J., & Peeper, D. S. (2008) · Cell · doi:10.1016/j.cell.2008.03.039 · Cited by 2,086
Cellular senescence and the senescent secretory phenotype: therapeutic opportunities
Tchkonia, T., Zhu, Y., van Deursen, J., Campisi, J., & Kirkland, J. L. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64098 · Cited by 1,774 · cited 4×
“Interventions directed at preventing the adverse effects associated with the SASP are being explored The most promising strategies involve delaying cellular senescence [15, 16]; SASP switch-off [17-20]; and selective removal or killing of existing senescent cells [1, 21].”
BackgroundInfluentialFreund, A., Patil, C. K., & Campisi, J. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.69 · Cited by 1,039
Hypothalamic programming of systemic ageing involving IKK-β, NF-κB and GnRH
Zhang, G., Li, J., Purkayastha, S., Tang, Y., Zhang, H., Yin, Y., Li, B., Liu, G., & Cai, D. (2013) · Nature · doi:10.1038/nature12143 · Cited by 834 · cited 1×
“Accordingly, the pathways involved in SASP acquisition, as the NF-kB and the IL-1/ NLRP3 inflammasome pathways are master modulators of the aging rate [7-12].”
Background
Research works printed but not linked: 32
- Campisi, 2010, Inflammatory networks during cellular senescence: causes and consequences, Trends Mol Med, 16, 238, 10.1016/j.molmed.2010.03.003 · DOI · Paper page
- Sharpless, 2013, Coming of age: molecular drivers of aging and therapeutic opportunities, J Clin Invest, 123, 946, 10.1172/JCI68833 · DOI · Paper page
- Ingram, 2013, Canonical Nlrp3 inflammasome links systemic low-grade inflammation to functional decline in aging, Cell Metab, 18, 519, 10.1016/j.cmet.2013.09.010 · DOI · Paper page
- Bernard, 2015, Screening of a kinase library reveals novel pro-senescence kinases and their common NF-κB-dependent transcriptional program, Aging (Albany NY), 7, 986
- Maier, 2012, The number of p16INK4a positive cells in human skin reflects biological age, Aging Cell, 11, 722, 10.1111/j.1474-9726.2012.00837.x · DOI · Paper page
- Jansen-Dürr, 2014, Methionine restriction slows down senescence in human diploid fibroblasts, Aging Cell, 13, 1038, 10.1111/acel.12266 · DOI
- Ming, 2015, Role of p38 mitogen-activated protein kinase in vascular endothelial aging: interaction with Arginase-II and S6K1 signaling pathway, Aging (Albany NY), 7, 70
- Adams, 2014, A comparison of oncogene-induced senescence and replicative senescence: implications for tumor suppression and aging, Age (Dordr), 36, 9637, 10.1007/s11357-014-9637-0 · DOI
- Rehman, 2009, Premature senescence of highly proliferative endothelial progenitor cells is induced by tumor necrosis factor-alpha via the p38 mitogen-activated protein kinase pathway, FASEB J, 23, 1358, 10.1096/fj.08-110296 · DOI · Paper page
- Ramírez, 2012, Klotho modulates the stress response in human senescent endothelial cells, Mech Ageing Dev, 133, 647, 10.1016/j.mad.2012.09.002 · DOI
- Zhang, 2009, Role of TNF-alpha in vascular dysfunction, Clin Sci (Lond), 116, 219, 10.1042/CS20080196 · DOI · Paper page
- Armstrong, 2014, Endothelial dysfunction and the effects of TNF inhibitors on the endothelium in psoriasis and psoriatic arthritis: a systematic review, Curr Pharm Des, 20, 513, 10.2174/138161282004140213123852 · DOI
- Kampoli, 2011, Anti-tumor necrosis factor α treatment with adalimumab improves significantly endothelial function and decreases inflammatory process in patients with chronic psoriasis, Int J Cardiol, 151, 382, 10.1016/j.ijcard.2011.06.112 · DOI
- Campanati, Moroncini, Ganzetti, Pozniak, Goteri, Giuliano, Martina, Liberati, Ricotti, Gabrielli, Offidani. adalimumab modulates angiogenesis in psoriatic skin eur j inflam. 2013; 11:489–498. · doi:10.1177/1721727x1301100218
- Prestinari, 2013, Immunogenicity of anti-TNFα therapy in psoriasis: a clinical issue?, Expert Opin Biol Ther, 13, 1673, 10.1517/14712598.2013.848194 · DOI
- Offidani, 2009, Angiogenesis in psoriatic skin and its modifications after administration of etanercept: videocapillaroscopic, histological and immunohistochemical evaluation, Int J Immunopathol Pharmacol, 22, 371, 10.1177/039463200902200214 · doi:10.1177/039463200902200214
- Piccolo, 2010, MicroRNA control of signal transduction, Nat Rev Mol Cell Biol, 11, 252, 10.1038/nrm2868 · DOI · Paper page
- Campisi, 1995, A biomarker that identifies senescent human cells in culture and in aging skin, Proc Natl Acad Sci U S A, 92, 9363, 10.1073/pnas.92.20.9363 · DOI · Paper page
- Cao, 2003, Immortalization of bovine capillary endothelial cells by hTERT alone involves inactivation of endogenous p16INK4A/pRb, FASEB J, 17, 764, 10.1096/fj.02-0599fje · DOI
- Tsao, 2001, eNOS activity is reduced in senescent human endothelial cells: Preservation by hTERT immortalization, Circ Res, 89, 793, 10.1161/hh2101.098443 · DOI · Paper page
- Kupper, 2002, A single dose, placebo controlled study of the fully human anti-tumor necrosis factor-alpha antibody adalimumab (D2E7) in patients with rheumatoid arthritis, J Rheumatol, 29, 2288
- Greene, 2010, miR-126 is downregulated in cystic fibrosis airway epithelial cells and regulates TOM1 expression, J Immunol, 184, 1702, 10.4049/jimmunol.0902669 · DOI · Paper page
- Arribas, 2015, Effect of cellular senescence on the growth of HER2-positive breast cancers, J Natl Cancer Inst, 107
- Bonafé, 2013, Peroxisome proliferator activated receptor-α/hypoxia inducible factor-1α interplay sustains carbonic anhydrase IX and apoliprotein E expression in breast cancer stem cells, PLoS One, 8, e54968, 10.1371/journal.pone.0054968 · DOI
- Bonafé, 2014, PPARγ and RXR ligands disrupt the inflammatory cross-talk in the hypoxic breast cancer stem cells niche, J Cell Physiol, 229, 1595, 10.1002/jcp.24601 · DOI
- Christophers, 1995, Disease concomitance in psoriasis, J Am Acad Dermatol, 32, 982, 10.1016/0190-9622(95)91336-X · DOI · Paper page
- Weinberg, 2014, From the Medical Board of the National Psoriasis Foundation: The risk of cardiovascular disease in individuals with psoriasis and the potential impact of current therapies, J Am Acad Dermatol, 70, 168, 10.1016/j.jaad.2013.09.020 · DOI
- Ferrucci, 2006, Interleukin-6 in aging and chronic disease: a magnificent pathway, J Gerontol A Biol Sci Med Sci, 61, 575, 10.1093/gerona/61.6.575 · DOI · Paper page
- Miller, 2014, Endothelial dysfunction in chronic inflammatory diseases, Int J Mol Sci, 15, 11324, 10.3390/ijms150711324 · DOI · Paper page
- Lio, 2013, NF-κB pathway activators as potential ageing biomarkers: targets for new therapeutic strategies, Immun Ageing, 10, 24, 10.1186/1742-4933-10-24 · DOI · Paper page
- Baranova, 2015, Age-independent rise of inflammatory scores may contribute to accelerated aging in multi-morbidity, Oncotarget, 6, 1414, 10.18632/oncotarget.2725 · DOI
- Olivieri, 2015, Endothelial cell senescence and inflammaging: microRNAs as biomarkers and innovative therapeutic tools, Curr Drug Targets
Cited by
Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study
Justice, J. N., Nambiar, A. M., Tchkonia, T., LeBrasseur, N. K., Pascual, R., Hashmi, S. K., Prata, L., Masternak, M. M., Kritchevsky, S. B., Musi, N., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2018.12.052 · Cited by 1,261
Franceschi, C., Garagnani, P., Vitale, G., Capri, M., & Salvioli, S. (2017) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2016.09.005 · Cited by 997
Senescent cell clearance by the immune system: Emerging therapeutic opportunities
Prata, L. G. P. L., Ovsyannikova, I. G., Tchkonia, T., & Kirkland, J. L. (2018) · Seminars in Immunology · doi:10.1016/j.smim.2019.04.003 · Cited by 497
Watanabe, S., Kawamoto, S., Ohtani, N., & Hara, E. (2017) · Cancer Science · doi:10.1111/cas.13184 · Cited by 321
Cellular senescence and SASP in tumor progression and therapeutic opportunities
Dong, Z., Luo, Y., Yuan, Z., Tian, Y., Jin, T., & Xu, F. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02096-7 · Cited by 259
Metadata
- Authors
- Prattichizzo, F., Giuliani, A., Recchioni, R., Bonafè, M., Marcheselli, F., De Carolis, S., Campanati, A., Giuliodori, K., Rippo, M. R., Brugè, F., Tiano, L., Micucci, C., Ceriello, A., Offidani, A., Procopio, A. D., & Olivieri, F.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2016-03-02
- Volume
- 7
- Issue
- 11
- Pages
- 11945-11958
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W2290128502
- Cited by
- 90
- References
- 23
- FWCI
- 7.53
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Anti-TNF-α treatment modulates SASP and SASP-related microRNAs in endothelial cells and in circulating angiogenic cells. https://app.cochat.ai/papers/10.18632/oncotarget.7858
- The paper
- Prattichizzo, F., Giuliani, A., Recchioni, R., Bonafè, M., Marcheselli, F., De Carolis, S., Campanati, A., Giuliodori, K., Rippo, M. R., Brugè, F., Tiano, L., Micucci, C., Ceriello, A., Offidani, A., Procopio, A. D., & Olivieri, F. (2016). Anti-TNF-α treatment modulates SASP and SASP-related microRNAs in endothelial cells and in circulating angiogenic cells. Oncotarget. https://doi.org/10.18632/oncotarget.7858
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.